Kristina Allikmets, MD PhD

Takeda Pharmaceuticals Inc.
40 Landsdown Str
Cambridge, MA
USA 02139
Papers:
3249 A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics